Full Issue

Individual Articles - Jul/Aug 2021 - Volume 25, Number 4

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2021 Pg. 268	PreScription: Endemics, Epidemics, and Pandemics Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 270-274	Growing a Compounding Practice: Successful Marketing to Underserved Populations Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2021 Pg. 276-281	Expecting the Expected: Planning Considerations for Cleanroom Construction Author(s): Roberts Patricia A, Kroon Laura
Jul/Aug 2021 Pg. 282-287	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2 Author(s): Riepl Mike
Jul/Aug 2021 Pg. 288-295	Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta
Jul/Aug 2021 Pg. 296-297	A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Author(s): Brunner Scott
Jul/Aug 2021 Pg. 298-302	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Jul/Aug 2021 Pg. 304-309	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 311-317	Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 318	Calculations Author(s): Stockton Shelly J
Jul/Aug 2021 Pg. 320	Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 322	BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 323	Budesonide 0.0.25% Mucoadhesive Gel Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 324	Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 325	Hydrocortisone 2-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 326	Moh's Paste, Modified Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 327	Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 328	Tacrolimus 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 329	Valsartan 4-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 330-335	Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions Author(s): Wolfe Amanda, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan
Jul/Aug 2021 Pg. 336-343	Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021 Pg. 344-351	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U